Using clinical characteristics and molecular markers to predict the risk of subsequent ipsilateral breast events after excision of DCIS

被引：0
|
作者：
Liu, Ying
Strand, Siri H.
King, Lorraine
Harmon, Bryan
Couch, Fergus J.
Gallagher, Kristalyn
Kilgore, Mark
Wei, Shi
DeMichele, Angela
King, Tari
McAuliffe, Priscilla F.
Marks, Jeffrey
Maley, Carlo
West, Robert
Hwang, E. Shelley
Colditz, Graham A.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P1-07-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-07-02
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Validation and calibration of breast cancer nomogram for predicting risk of ipsilateral breast tumour recurrences in asian population with ductal carcinoma in situ after local excision
    Wang, F.
    Li, H. H.
    Tan, P. H.
    Wong, F. Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S443 - S443
  • [32] Subsequent invasive breast cancer risk after DCIS treatment in multinational PRECISION consortium cohorts comprising 48,576 patients
    Schmitz, Renee S.
    van den Belt-Dusebout, Alexandra W.
    Clements, Karen
    Ren, Yi
    Cresta, Chiara
    Timbres, Jasmine
    Liu, Yat-Hee
    Byng, Danalyn
    Lynch, Thomas
    Menegaz, Brian
    Collyar, Deborah
    Hyslop, Terry
    Schaapveld, Michael
    Sawyer, Elinor
    Hwang, Shelley E.
    Thompson, Alastair
    Ryser, Marc D.
    Wesseling, Jelle
    Lips, Esther H.
    Schmidt, Marjanka K.
    CANCER RESEARCH, 2022, 82 (12)
  • [33] Histoplathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast -: Results from the Swedish randomised trial
    Ringberg, A.
    Nordgren, H.
    Thorstensson, S.
    Idvall, I.
    Garmo, H.
    Granstrand, B.
    Arnesson, L. G.
    Sandelin, K.
    Wallgren, A.
    Anderson, H.
    Emdin, S.
    Holmberg, L.
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (02) : 291 - 298
  • [34] A Nomogram Using Imaging Features to Predict Ipsilateral Breast Tumor Recurrence After Breast- Conserving Surgery for Ductal Carcinoma In Situ
    Choi, Bo Hwa
    Kang, Soohee
    Cho, Nariya
    Kim, Soo-Yeon
    KOREAN JOURNAL OF RADIOLOGY, 2024, 25 (10) : 876 - 886
  • [35] Risk for subsequent breast cancer after lobular carcinoma in situ: Do clinical factors matter?
    Muhsen, S.
    Morrogh, M.
    Andrade, A. P.
    Sakr, R.
    Paik, W.
    Morrow, M.
    King, T. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management
    Kleibl, Zdenek
    Kristensen, Vessela N.
    BREAST, 2016, 28 : 136 - 144
  • [37] Clinical characteristics and molecular markers predicting the development and outcome of breast cancer brain metastases.
    Melisko, ME
    Chew, K
    Baehner, F
    Moore, D
    Sneed, PK
    Rugo, HS
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S55 - S55
  • [38] Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy - Comparison with clinical and biologic factors
    Goldstein, NS
    Vicini, FA
    Hunter, S
    Odish, E
    Forbes, S
    Kraus, D
    Kestin, LL
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (05) : 679 - 689
  • [39] Comparison of Risk of Ipsilateral Breast Event After Lumpectomy for Ductal Carcinoma In Situ, As Estimated by Breast Radiation Oncologists, Van Nuys Prognostic Index, Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-gene DCIS Score
    Lei, R. Y.
    Carter, D. L.
    Antell, A. G.
    Nowels, M. A.
    Fryman, S. P.
    Janotta, E.
    Leonard, C. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E45 - E45
  • [40] Risk of metastases after ipsilateral breast tumour recurrence changes overtime according to patient and tumour characteristics: Implications for treatment
    Gennaro, M.
    Di Cosimo, S.
    Ardoino, I.
    Veneroni, S.
    Mariani, L.
    de Braud, F.
    Daidone, M. G.
    Biganzoli, E.
    Demicheli, R.
    CANCER RESEARCH, 2017, 77
12345